1. Home
  2. OCS vs NRDS Comparison

OCS vs NRDS Comparison

Compare OCS & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • NRDS
  • Stock Information
  • Founded
  • OCS 2003
  • NRDS 2009
  • Country
  • OCS Switzerland
  • NRDS United States
  • Employees
  • OCS N/A
  • NRDS N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • NRDS EDP Services
  • Sector
  • OCS Health Care
  • NRDS Technology
  • Exchange
  • OCS Nasdaq
  • NRDS Nasdaq
  • Market Cap
  • OCS 916.3M
  • NRDS 1.0B
  • IPO Year
  • OCS N/A
  • NRDS 2021
  • Fundamental
  • Price
  • OCS $21.41
  • NRDS $10.33
  • Analyst Decision
  • OCS Strong Buy
  • NRDS Buy
  • Analyst Count
  • OCS 5
  • NRDS 5
  • Target Price
  • OCS $28.80
  • NRDS $17.60
  • AVG Volume (30 Days)
  • OCS 64.5K
  • NRDS 660.8K
  • Earning Date
  • OCS 03-17-2025
  • NRDS 02-19-2025
  • Dividend Yield
  • OCS N/A
  • NRDS N/A
  • EPS Growth
  • OCS N/A
  • NRDS N/A
  • EPS
  • OCS N/A
  • NRDS 0.38
  • Revenue
  • OCS $1,027,571.00
  • NRDS $687,600,000.00
  • Revenue This Year
  • OCS $7.98
  • NRDS $14.44
  • Revenue Next Year
  • OCS $853.39
  • NRDS $13.10
  • P/E Ratio
  • OCS N/A
  • NRDS $27.18
  • Revenue Growth
  • OCS N/A
  • NRDS 14.71
  • 52 Week Low
  • OCS $10.55
  • NRDS $10.10
  • 52 Week High
  • OCS $23.08
  • NRDS $17.30
  • Technical
  • Relative Strength Index (RSI)
  • OCS 52.07
  • NRDS 21.71
  • Support Level
  • OCS $20.95
  • NRDS $13.25
  • Resistance Level
  • OCS $21.86
  • NRDS $14.45
  • Average True Range (ATR)
  • OCS 0.56
  • NRDS 0.75
  • MACD
  • OCS -0.26
  • NRDS -0.36
  • Stochastic Oscillator
  • OCS 56.18
  • NRDS 3.38

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About NRDS NerdWallet Inc.

Nerdwallet Inc is a company that provides onsumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. They get revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.

Share on Social Networks: